Siemens Expands Capacity for Wind Turbines

In response to the continuing high demand for wind turbines worldwide, Siemens Wind Power A/S is expanding its production capacity. With this aim, the company has acquired a former LM Glasfiber factory at Engesvang in Denmark for manufacturing rotor blades. Siemens is investing heavily in the assembly plant at its headquarters in Brande and in the rotor blade manufacturing facility in Aalborg to obtain a further increase in capacity. The total investment volume amounts to more than EUR50 million.

The Siemens Power Generation Group (PG) is experiencing sharp growth in the wind energy sector. Compared to the previous year, in 2005, Siemens PG nearly doubled its wind turbine sales, with turbines of nearly 630 megawatts of output leaving the factory. Fabrication capacity for 2006 is almost fully booked for the assembly plant at the division headquarters in Brande and for the rotor blade manufacturing facility in Aalborg. In response to this, series production of rotor blades for wind turbines is scheduled to begin in Engesvang in early 2006.

“Expansion of our capacities in Denmark is the first step in building a worldwide manufacturing network,” said Andreas Nauen, head of the Wind Power division at Siemens Power Generation. “We have high expectations from the new factory, which will allow us to provide a faster and more flexible response to market requirements. A further aim is to access the glass fiber manufacturing know-how and expertise available at this location,” Nauen added.

The blade factory will use the IntegralBlade technology patented by Siemens. With this technology, the blades are cast in one piece in a single step from glass-fiber-reinforced epoxy resin in a closed, environmentally compatible process.

Since the Siemens acquisition of Bonus Energy A/S in December 2004, more than 700 new employees have been hired in Denmark. Siemens Wind Power currently employs approximately 1800 people worldwide.

http://www.siemens.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.